A chair-stand time of greater than 15 seconds is associated with an increased risk of death and hospitalization in cirrhosis

• Published in: Canadian liver journal Vol. 6; no. 3; pp. 358 - 362
• Main Authors: Nguyen, Vivian V, Wang, Sarah, Whitlock, Reid, Xu, Chelsea, Taneja, Sunil, Singh, Surender, Abraldes, Juan G, Burak, Kelly, Bailey, Robert J, Grab, Joshua D, Lai, Jennifer C, Tandon, Puneeta
• Format: Journal Article
• Language: English
• Published: Canada University of Toronto Press 01.10.2023
• Subjects: Health aspects; Liver; Liver cirrhosis; Prognosis; Alberta; Canada; mortality; frailty; cirrhosis
• ISSN: 2561-4444; 2561-4444
• DOI: 10.3138/canlivj-2022-0021

Frailty is a clinical state of increased vulnerability and is common in patients with cirrhosis. The liver frailty index (LFI) is a validated tool to evaluate frailty in cirrhosis, comprising of grip strength, chair stands, and balance tests. The chair-stand test is an easy to conduct frailty subcomponent that does not require specialized equipment and may be valuable to predict adverse clinical outcomes in cirrhosis. The objective of this study was to determine if the chair-stand test is an independent predictor of mortality and hospitalization in cirrhosis. A retrospective review of 787 patients with cirrhosis was conducted. Chair-stand times were collected at baseline in person and divided into three groups: <10 seconds ( = 276), 10-15 seconds ( = 290), and >15 seconds ( = 221). Fine-Gray proportional hazards regression models were used to evaluate the association between chair-stand times and the outcomes of mortality and non-elective hospitalization. The hazard of mortality (HR 3.21, 95% CI 2.16%-4.78%, <0.001) and non-elective hospitalization (HR 2.24, 95% CI 1.73%-2.91%, <0.001) was increased in group 3 in comparison to group 1. A chair-stand test time >15 seconds had increased all-cause mortality (HR 2.78, 95% CI 2.01%-3.83%, <0.001) and non-elective hospitalizations (HR 1.84, 95% CI 1.48%-2.29%, <0.001) compared to <15 seconds. A chair-stand test time of >15 seconds is independently associated with mortality and non-elective hospitalizations. This test holds promise as a rapid prognostication tool in cirrhosis. Future work will include external validation and virtual assessment in this population.